{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:29:59Z","timestamp":1786728599285,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jcrt.jcrt_1055_16","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T07:03:51Z","timestamp":1532329431000},"page":"7-12","source":"Crossref","is-referenced-by-count":10,"title":["Xist noncoding RNA could act as a tumor suppressor gene in patients with classical Hodgkin's disease"],"prefix":"10.4103","volume":"16","author":[{"given":"Stefano","family":"Parodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20230628","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1146\/annurev.genet.42.110807.091711","article-title":"X chromosome dosage compensation: How mammals keep the balance","volume":"42","author":"Payer","year":"2008","journal-title":"Annu Rev Genet"},{"key":"R2-1-20230628","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1097-2765(00)80248-8","article-title":"A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation","volume":"5","author":"Wutz","year":"2000","journal-title":"Mol Cell"},{"key":"R3-1-20230628","doi-asserted-by":"crossref","first-page":"e2203","DOI":"10.1038\/cddis.2016.100","article-title":"MicroRNA-92b promotes hepatocellular carcinoma progression by targeting smad7 and is mediated by long non-coding RNA XIST","volume":"7","author":"Zhuang","year":"2016","journal-title":"Cell Death Dis"},{"key":"R4-1-20230628","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/cancers3022169","article-title":"X inactivation and progenitor cancer cells","volume":"3","author":"Agrelo","year":"2011","journal-title":"Cancers (Basel"},{"key":"R5-1-20230628","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbrc.2016.08.030","article-title":"Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression","volume":"478","author":"Fang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-1-20230628","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(03)15170-7","article-title":"XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer","volume":"363","author":"Kawakami","year":"2004","journal-title":"Lancet"},{"key":"R7-1-20230628","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2014.12.051","article-title":"Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152","volume":"359","author":"Yao","year":"2015","journal-title":"Cancer Lett"},{"key":"R8-1-20230628","first-page":"769","article-title":"Relationship of XIST expression and responses of ovarian cancer to chemotherapy","volume":"1","author":"Huang","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"R9-1-20230628","doi-asserted-by":"crossref","first-page":"43256","DOI":"10.18632\/oncotarget.9673","article-title":"Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"R10-1-20230628","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2013.01.034","article-title":"Xist RNA is a potent suppressor of hematologic cancer in mice","volume":"152","author":"Yildirim","year":"2013","journal-title":"Cell"},{"key":"R11-1-20230628","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.devcel.2009.03.006","article-title":"SATB1 defines the developmental context for gene silencing by xist in lymphoma and embryonic cells","volume":"16","author":"Agrelo","year":"2009","journal-title":"Dev Cell"},{"key":"R12-1-20230628","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1460458216655188","article-title":"Logic learning machine and standard supervised methods for Hodgkin's lymphoma prognosis using gene expression data and clinical variables","volume":"24","author":"Parodi","year":"2018","journal-title":"Health Informatics J"},{"key":"R13-1-20230628","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"key":"R14-1-20230628","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"R15-1-20230628","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","article-title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","volume":"120","author":"Steidl","year":"2012","journal-title":"Blood"},{"key":"R16-1-20230628","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"R17-1-20230628","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2005-12-5125","article-title":"Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma","volume":"108","author":"S\u00e1nchez-Aguilera","year":"2006","journal-title":"Blood"},{"key":"R18-1-20230628","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.1768","article-title":"Expression of the NF-kappaB targets BCL2 and BIRC5\/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively","volume":"206","author":"Tracey","year":"2005","journal-title":"J Pathol"},{"key":"R19-1-20230628","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","article-title":"Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome","volume":"113","author":"Chetaille","year":"2009","journal-title":"Blood"},{"key":"R20-1-20230628","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/sj.onc.1205418","article-title":"Gene expression profiling defines molecular subtypes of classical Hodgkin's disease","volume":"21","author":"Devilard","year":"2002","journal-title":"Oncogene"},{"key":"R22-1-20230628","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"R23-1-20230628","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"R24-1-20230628","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00268-010-0951-0","article-title":"Expression and function of a large non-coding RNA gene XIST in human cancer","volume":"35","author":"Weakley","year":"2011","journal-title":"World J Surg"},{"key":"R25-1-20230628","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease.International prognostic factors project on advanced Hodgkin's disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"R26-1-20230628","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1532\/IJH97.06048","article-title":"Genomic alterations in Hodgkin's lymphoma","volume":"83","author":"Weniger","year":"2006","journal-title":"Int J Hematol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1055_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:29:05Z","timestamp":1786724945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1055_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1055_16","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}